Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 4
1989 2
1991 2
1992 1
1994 3
1995 1
1997 2
2000 1
2002 3
2004 1
2005 3
2006 2
2007 1
2008 3
2012 1
2014 1
2015 1
2016 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant chemotherapy in 2005: standards and beyond.
Piccart MJ, de Valeriola D, Dal Lago L, de Azambuja E, Demonty G, Lebrun F, Bernard-Marty Ch, Colozza M, Cufer T. Piccart MJ, et al. Among authors: de valeriola d. Breast. 2005 Dec;14(6):439-45. doi: 10.1016/j.breast.2005.08.004. Epub 2005 Sep 26. Breast. 2005. PMID: 16188441 Review.
Anthracyclines active via the oral route: luxury or necessity?
Piccart MJ, de Valeriola D, Tomiak E. Piccart MJ, et al. Among authors: de valeriola d. Ann Oncol. 1992 Mar;3(3):181-2. doi: 10.1093/oxfordjournals.annonc.a058144. Ann Oncol. 1992. PMID: 1534020 Free article. No abstract available.
Need for global action for cancer control.
Boyle P, Anderson BO, Andersson LC, Ariyaratne Y, Auleley GR, Barbacid M, Bartelink H, Baselga J, Behbehani K, Belardelli F, Berns A, Bishop J, Brawley O, Burns H, Clanton M, Cox B, Currow D, Dangou JM, de Valeriola D, Dinshaw K, Eggermont A, Fitzpatrick J, Forstmane M, Garaci E, Gavin AT, Kakizoe T, Kasler M, Keita N, Kerr D, Khayat D, Khleif S, Khuhaprema T, Knezevic T, Kubinova R, Mallath M, Martin-Moreno J, McCance D, McVie JG, Merriman A, Ngoma T, Nowacki M, Orgelbrand J, Park JG, Pierotti M, Ashton LP, Puska P, Escobar CV, Rajan B, Rajkumar T, Ringborg U, Robertson C, Rodger A, Roovali L, Santini LA, Sarhan M, Seffrin J, Semiglazov V, Shrestha BM, Soo KC, Stamenic V, Tamblyn C, Thomas R, Tuncer M, Tursz T, Vaitkiene R, Vallejos C, Veronesi U, Wojtyla A, Yach D, Yoo KY, Zatonski W, Zaridze D, Zeng YX, Zhao P, Zheng T. Boyle P, et al. Among authors: de valeriola d. Ann Oncol. 2008 Sep;19(9):1519-21. doi: 10.1093/annonc/mdn426. Ann Oncol. 2008. PMID: 18723552 Free article. No abstract available.
Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks.
Kehrloesser S, Oberst S, Westerhuis W, Wendler A, Wind A, Blaauwgeers H, Burrion JB, Nagy P, Saeter G, Gustafsson E, De Paoli P, Lovey J, Lombardo C, Philip T, de Valeriola D, Docter M, Boomsma F, Saghatchian M, Svoboda M, Philip I, Monetti F, Hummel H, McVie G, Otter R, van Harten W. Kehrloesser S, et al. Among authors: de valeriola d. Mol Oncol. 2021 May;15(5):1277-1288. doi: 10.1002/1878-0261.12950. Epub 2021 Mar 30. Mol Oncol. 2021. PMID: 33734563 Free PMC article.
Tobacco: deadly in any form or disguise.
Boyle P, Ariyaratne MA, Barrington R, Bartelink H, Bartsch G, Berns A, de Valeriola D, Dinshaw KA, Eggermont AM, Gray N, Kakizoe T, Karki BS, Kaslar M, Kerr DJ, Khayat D, Khuhaprema T, Kim IH, Martin-Moreno J, McVie G, Park JG, Philip T, Ringborg U, Rodger A, Seffrin JR, Semiglazov V, Soo KC, Sun YT, Thomas R, Tursz T, Veronesi U, Wiestler O, Yoo KY, Zatonski W, Zhao P. Boyle P, et al. Among authors: de valeriola d. Lancet. 2006 May 27;367(9524):1710-2. doi: 10.1016/S0140-6736(06)68747-3. Lancet. 2006. PMID: 16731252 No abstract available.
Dose optimization of anthracyclines.
de Valeriola D. de Valeriola D. Anticancer Res. 1994 Nov-Dec;14(6A):2307-13. Anticancer Res. 1994. PMID: 7825964 Review.
Phase I clinical trial with carbetimer.
Dodion P, de Valeriola D, Body JJ, Houa M, Noel P, Abrams J, Crespeigne N, Wery F, Kenis Y. Dodion P, et al. Among authors: de valeriola d. Eur J Cancer Clin Oncol. 1989 Feb;25(2):279-86. doi: 10.1016/0277-5379(89)90020-5. Eur J Cancer Clin Oncol. 1989. PMID: 2539292
Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial.
Aftimos P, Polastro L, Ameye L, Jungels C, Vakili J, Paesmans M, van den Eerenbeemt J, Buttice A, Gombos A, de Valeriola D, Gil T, Piccart-Gebhart M, Awada A. Aftimos P, et al. Among authors: de valeriola d. Eur J Cancer. 2016 Jun;60:117-24. doi: 10.1016/j.ejca.2016.03.010. Epub 2016 Apr 20. Eur J Cancer. 2016. PMID: 27107326 Clinical Trial.
34 results